AmSurg buying Dallas chain
Cash deal will add 18 surgery centers in nine states
Apr 7, 2011 2:55 PM
|
Zacks downgrades AmSurg
Zacks Investment Research has downgraded shares of ambulatory surgery center company AmSurg to 'underperform' and with a price target of $23, citing continued economic uncertanties that could hinder volumes, as well as bottom-line pressures from higher interest expenses and a higher tax rate.
Shares of AmSurg (Ticker: AMSG) closed Friday at $25.29.
Apr 4, 2011 7:20 AM
Court dismisses AmSurg suit against former exec
AmSurg has lost the first round of its legal fight against a former executive it says breached his contract by hiring away his former subordinates after leaving the Nashville ambulatory surgery center company. Outpatient Surgery magazine reports that a Nashville judge dismissed the case after Frank Principati, a former AmSurg division president, argued the Tennessee court lacked jurisdiction over the case because he lives and works in Pennsylvania.
An AmSurg attorney declined to comment to the magazine. It's unclear whether the company will move the case to Pennsylvania.
For the back story, see the Post's July story on AmSurg's suit.
Mar 15, 2011 2:13 PM
AmSurg boss in line for bigger bonus
Mar 2, 2011 7:31 AM
AmSurg 'running in place'
Stephens Inc. analyst Andreas Dirnagl has lowered his 2011 earnings per share estimate for Nashville's AmSurg — to $1.66 from a $1.78 — on expectations of continued volume weakness and delays in closing some clinic acquisitions. AmSurg (Ticker: AMSG) last week reported fourth quarter 2010 and year-end financial results that included a slight improvement in same-store results, given that volumes were flat instead of down. Dirnagl wrote in a research note to investors last week: "We note that 2011 would represent the third year of effectively flat/negative EPS growth, meaning that AMSG (and its holders) has been effectively running in place for an extended period of time." Feb 28, 2011 1:49 PM
Earnings wrap: Community Health Systems, AmSurg
Acquisitions aid both companies; CHS eyes growth while AmSurg guides downward
Feb 24, 2011 6:27 PM
BlackRock adds to AmSurg, America Service stakes
Feb 4, 2011 10:25 AM
AmSurg tweaks exec bonus plans
Ambulatory surgery center company AmSurg Corp. has altered its 2011 cash bonus plan to stress the attainment of personal goals and deemphasize the company’s earnings performance in determining the yearly boost for senior executives. According to a filing with the Securities and Exchange Commission, cash bonuses for President and CEO Chris Holden, EVP and CFO Claire Gulmi, and SVP and Chief Accounting Officer Kevin Eastridge will be based:- 30% on attainment of company earning targets,
- 30% on attainment of personal performance goals,
- 20% on targets related to surgery center profits, and
- 20% on annual earnings of acquired and de novo centers formed during 2011.
Feb 2, 2011 1:10 PM
Analyst action: AmSurg, LP
Deutsche Bank yesterday raised its price target on shares of local ambulatory surgery center company AmSurg from $20 to $24. It has the stock rated 'hold.'While AMSG trades at a discounted valuation and is favorably leveraged to a recovery in health care service volumes, DB continues to believe the fundamental outlook in the ASC space remains challenging due to excess capacity and weak pricing power.Shares of AmSurg (Ticker: AMSG) closed at $21.87 on Tuesday. The company has struggled with low procedure volumes in recent quarters, but investors anticipate a turnaround this year from favorable provisions in the health reform law. Analyst Paul Quinn at RBC Capital Markets has downgraded shares of Louisiana-Pacific to 'sector perform' from 'outperform.' His price target of $10 leaves no upside — LP shares (Ticker: LPX) closed Tuesday trading at $10.01 — but is still a good bit more upbeat than UBS researcher Gail Glazerman's.
Jan 19, 2011 8:07 AM
Investors see brighter 2011 for AmSurg
Shares of AmSurg ended Tuesday 2 percent higher on more than double their typical trading volume as investors look forward to an economic recovery that should help boost patient volumes for the Nashville surgery center chain in early 2011. AmSurg struggled with volumes all year as cash-strapped patients put off elective procedures. But starting in January, the new health reform law eliminates co-pays for colonoscopies — which represent about 25 percent of the company's GI business. Add to that a rise in consumer confidence, and AmSurg could reap the benefits of pent up patient demand with upticks in volume in the first and second quarters, according to the local office of Jefferies & Co. AmSurg (Ticker: AMSG) closed at $20.80 per share Tuesday. Year-to-date shares are down about 5.5 percent. Dec 15, 2010 7:31 AM
